Early research (Phase 1)Looking for participantsNCT05642182What this trial is testingStudy of SFA002 in Patients with Mild to Moderate Psoriasis PlaquesWho this might be right forPsoriasis SFA Therapeutics 90
Large-scale testing (Phase 3)Study completedNCT01001208What this trial is testingThe Efficacy and Safety of Adding Methotrexate to Etanercept in PsoriasisWho this might be right forPsoriasis Amgen 478
Testing effectiveness (Phase 2)Looking for participantsNCT07233291What this trial is testingA Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in AdultsWho this might be right forPsoriasis (PsO) Ahmed Ibrahim 36
Post-approval studies (Phase 4)WithdrawnNCT04488185What this trial is testingAn Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal UltrasoundWho this might be right forPsoriasis Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT05272150What this trial is testingStudy of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp PsoriasisWho this might be right forPlaque PsoriasisScalp Psoriasis Janssen Research & Development, LLC 211
Early research (Phase 1)Ended earlyNCT01493518What this trial is testingSafety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With PsoriasisWho this might be right forPsoriasis Amgen 6
Testing effectiveness (Phase 2)Study completedNCT00156247What this trial is testingAcitretin and Etanercept in PsoriasisWho this might be right forPsoriasis University of Medicine and Dentistry of New Jersey 10
Large-scale testing (Phase 3)Study completedNCT01241591What this trial is testingA Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Pfizer 1,101
Large-scale testing (Phase 3)Study completedNCT01726933What this trial is testingLAS41008 in Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPlaque Psoriasis Almirall, S.A. 839
Large-scale testing (Phase 3)Study completedNCT02362789What this trial is testingSecukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional BiomarkersWho this might be right forPsoriasis Novartis Pharmaceuticals 132
Large-scale testing (Phase 3)Study completedNCT01807520What this trial is testingStudy of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Nail PsoriasisWho this might be right forModerate to Severe Nail Psoriasis Novartis Pharmaceuticals 198
Large-scale testing (Phase 3)UnknownNCT06110676What this trial is testingEvaluate the Efficacy and Safety of LZM012Who this might be right forPsoriasis Livzon Pharmaceutical Group Inc. 918
Large-scale testing (Phase 3)Study completedNCT03875482What this trial is testingAssess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis AbbVie 157
Early research (Phase 1)Ended earlyNCT02502188What this trial is testingPhase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type PsoriasisWho this might be right forParapsoriasisHealthy Volunteers Celgene 24
Not applicableStudy completedNCT01077232What this trial is testingDocumentation of Humira in Psoriasis Patients in Routine Clinical PracticeWho this might be right forModerate to Severe Plaque Psoriasis AbbVie (prior sponsor, Abbott) 5,442
Large-scale testing (Phase 3)Study completedNCT00710580What this trial is testingStudy Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis AbbVie (prior sponsor, Abbott) 350
Not applicableLooking for participantsNCT04806620What this trial is testingUnhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchWho this might be right forPost-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more Brain Inflammation Collaborative 10,000
Large-scale testing (Phase 3)Study completedNCT04761627What this trial is testingInvestigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Amgen 494
Post-approval studies (Phase 4)Study completedNCT00940862What this trial is testingEffect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasisVascular InflammationCoronary Atherosclerosis Innovaderm Research Inc. 30
Large-scale testing (Phase 3)Study completedNCT00338754What this trial is testingAdalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Abbott 160